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A B S T R A C T
Purpose: Over the last few decades, preferred epilepsy surgical approaches have developed from
standard lobectomies to individually tailored resections. Yet, it remains uncertain how small surgical
interventions can be without compromising the success of the surgery. Particularly in patients with
epileptogenic lesions identiﬁed by magnetic resonance imaging (MRI), it is unresolved whether resection
or destruction of the lesion sufﬁces to eliminate the epileptogenic zone. We present a minimally invasive
surgical approach that may provide insight into this issue.
Methods: Two patients with pharmacoresistant epilepsy due to focal cortical dysplasia type IIB
demonstrated by 3 Tesla MRI were treated with lesion-focused stereotactic radio-frequency thermo-
coagulation. In both patients, pathognomonic epileptic discharges were recorded from the lesion via a
stimulation device prior to coagulation. In one patient, the suspected proximity of the lesion to the
pyramidal tract was veriﬁed by eliciting motor evoked potentials from the depths of the lesion.
Results: Following complete and near complete lesion destruction, seizures (several per day or per week,
respectively) ceased in patients A and B, with no seizures for 12 months and 5 months, respectively, at
the time of this publication. Neither patient acquired persistent postoperative neurological deﬁcits.
Conclusion: The fact that seizure activity stopped after destruction of small bottom-of-sulcus dysplasias
implies that in these cases, the epileptogenic zone and the epileptogenic lesion may overlap. If future
studies can replicate this ﬁnding, focused lesion destruction could be a further development of
individually tailored epilepsy surgery. The technique described here is especially suited for high-
precision surgery close to eloquent brain structures.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Over the last few decades, tailored epilepsy surgery has
successively replaced standard lobectomies. This development
was enabled by the availability of 1.5- and 3-Tesla magnetic
resonance imaging (MRI), which enables the detection of
epileptogenic lesions and their demarcation against non-
lesional tissue. The signiﬁcance of epileptogenic lesions is
indicated by the fact that incomplete resection is usuallyAbbreviations: EEG, electroencephalography; EZ, epileptogenic zone; FCD IIB, focal
cortical dysplasia type IIB; RFTC, radio-frequency thermo-coagulation; MRI,
magnetic resonance imaging; 3D-FLAIR, three dimensionally acquired ﬂuid
attenuated inversion recovery MRI sequence.
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http://dx.doi.org/10.1016/j.seizure.2014.01.024associated with poor outcome.1 It is less clear, however, in
which cases epileptogenic lesions as visualised by MRI, and the
epileptogenic zone (EZ) as deﬁned by Lu¨ders,2 overlap
completely, and when circumscribed lesionectomy or destruc-
tion is sufﬁcient for seizure control. The study of small bottom-
of-sulcus focal-cortical dysplasias (FCD) type IIB could help
elucidate this.3 According to intralesional electroencephalogra-
phy (EEG), these are intrinsically epileptogenic,4 and limited
resections concentrating on the cortical aspect of the lesions
sufﬁce for seizure freedom.5
We report two cases of lesion-focused stereotactic radio-
frequency thermo-coagulation (RFTC) in patients with epilepsy
due to circumscribed FCD IIB. Using MRI to guide coagulation
distinguishes our approach from primarily stereo-EEG guided
RFTC, which only rarely leads to seizure freedom.6 Postoperative
seizure control in both cases supports the idea that for some lesion
entities, the EZ may be restricted to the morphological anomaly.vier Ltd. All rights reserved.
Table 1





Seizure type and semiology Number of
lifetime AED
AED at surgery and at last visit Persistent neurological
deﬁcit
Patient A 9 39 SPS, CPS, sGTCS initiation by
jerks in left face
19 Phenytoin 450 mg/day down to 125 mg/day None
Patient B 18 46 Hypermotor SPS, CPS and sGTCS 3 Lamotrigin 450 mg/day down to 400 mg/day None
SPS, single partial seizures; CPS, complex-partial seizures; sGTCS, secondary generalised tonic–clonic seizures; AED, antiepileptic drugs.
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A 39-year-old (patient A) and a 46-year-old patient (patient B)
suffered from epilepsy with several seizures per day (patient A)
and per week (patient B) despite pharmacological treatment for
30 and 28 years. In both patients, 3 Tesla MRI including a three
dimensional 1 mm  1 mm  1 mm ﬂuid-attenuated inversion
recovery (3D-FLAIR) sequence showed the typical signs of singular,
circumscribed FCD IIB. Both lesions were identiﬁed as being
epileptogenic lesions by non-invasive presurgical workup. For
clinical details see Table 1.
An extended lesionectomy was offered to each patient with an
estimated chance for long term seizure freedom of 80% but a
signiﬁcant risk of permanent neurological morbidity. In patient A,
the lesion was located in the right pre-central gyrus close to the
neocortical face representation. More importantly, the deep parts
of the lesion reached the pyramidal tract (Fig. 1(A1)); therefore, the
risk of paresis following resection was estimated at 50%. In patient
B, the left fronto-orbital lesion did not immediately neighbourFig. 1. (A1) 3 Tesla MRI (1 mm  1 mm  1 mm FLAIR) clearly indicates the existence of a 
thickened cortex to the ventricle wall. Insert A1: the lesion (*) is located close to the hand
imaging. (A2) In patient A, six trajectories where chosen to impale the lesion (yellow ou
imaging-based ﬁbre tracking (light red). (A3–5) Blue spheres indicate the sites within t
indicate the sites of stimulation for motor evoked potentials; and red spheres indicate t
extinction of the previous lesion. (B1) Also in patient B, the high resolution 3D-FLAIR indi
trajectories were chosen to allow coagulation of the lesion (screenshot of the coagulation
minimal amount of oedema around the coagulation sites, which is equivalent to the aeloquent cortex or ﬁbre tracts (Fig. 1(B1)), but complications
during an open sub-frontal surgical approach could have resulted
in aphasic disturbance.
The patients were informed about alternative local lesion
destruction via stereotactic RFTC. Based on clinical and in vivo data
relating the dimensions of tissue defects to the applied electrode
type, temperature and heating time,7,8 together with the large
clinical experience from the application of this technology for
functional stereotactic neurosurgery (thalamotomy, pallidotomy),
the procedural risk was estimated to be lower than that of
conventional surgery. Experience regarding the chances for seizure
freedom following lesion-oriented RFTC was lacking. However, for
the case of complete lesion destruction, a similar chance for seizure
freedom as for the case of lesionectomy was projected. Both
patients opted for the RFTC.
RFTC was planned based on the lesion extent recognisable on
3 Tesla 3D-FLAIR, coregistered to a contrast enhanced 3D-T1 to
prevent penetration of blood vessels by the electrode. For the
deﬁnition of coagulation points and trajectories, we usedFCD type IIB of Palmini and Lu¨ders (arrow) with a funnel-like signal extension from a
-representation of the precentral gyrus according to functional magnetic resonance
tline), which is located close to the pyramidal tract according to diffusion weighted
he lesion at which a bipolar EEG was recorded via the RFTC device; green spheres
he ﬁnal coagulation sites. (A6) MRI of patient A one year after RFTC documents the
cates a FCD IIB with trans mantle sign towards the ventricle. (B2) In patient B, seven
 plan). (B3) The 3D-FLAIR of patient B two months after intervention indicates only a
mount of oedema patient A showed at 3 months post-op (not shown).
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Germany) developed for stereotactic brachytherapy of intracere-
bral tumours with iodine-125 seeds.9 Relying on the known
volume and shape of ablated tissue resulting from heating (80 8C
for 60 s = 60 mm3) with a bipolar radio frequency probe (TCB013,
Inomed, Freiburg, Germany), partially overlapping coagulation
sites were planned to ablate the lesions. Because of the complex
lesion anatomy, six and seven trajectories for patients A and B,
respectively, via four 8 mm burr-holes were necessary (Fig. 1(A2)
and (B2)).
RFTC was performed under general anaesthesia. A stimulation
electrode was inserted via a Riechert-Mundiger frame (TA, Precisis
AG, Walldorf, Germany). Epileptogenicity of the lesions was
veriﬁed at all planned coagulation sites and at additional sites
within the trajectories by bipolar 1 channel EEG via the contacts at
the macroelectrode tip (Fig. 1(A3)). In both patients, FCD-typical
repetitive spikes were detected within the lesion.
In patient A, motor evoked potentials (MEP) were elicited via
the probe (Fig. 1(A4)) at sites that were suspected to be close to the
pyramidal tract. At one site, electrical stimulation triggered a
typical seizure with left periorbital jerks. At 7 sites, electrical
stimulation elicited motor function, documented by MEP-electro-
des and by visual inspection (2 left thumb; 7 left chin/mouth).
EEG and MEP were recorded with an XLTEK 32 IOM system (Natus
Medical, San Carlos, CA).
RFTC was ﬁnally performed at 16 (patient A, Fig. 1(A5)) and
14 (patient B) sites using a 500 kHz radiofrequency generator
(NeuroN50, Inomed, Freiburg, Germany). In both patients, only
minor modiﬁcations from the original plan were made: (i) one and
two additional coagulation sites were added for patients A and B,
respectively, within the planned trajectories because of intense
epileptic discharge activity; (ii) in patient A two existing
trajectories were extended forward by 4.8 and 3 mm because
of intense epileptic activity at the planned deepest position; (iii)
also in patient A, in one trajectory all three planned stimulation
sites were shifted forward by 3 mm. Four coagulations were
performed in patient A despite proof of motor function because
of prominent epileptic discharges (three occurrences of a chin
motor response, one occurrence of mouth and discrete thumb
activity at high stimulation intensities – interpreted as remote
activation).
3. Results
Focal necroses resulting from the RFTC-procedures are shown
in Fig. 1(A6) and (B3). At three months, the coagulation sites are
surrounded by a slight non-space-occupying oedema. One year
after the intervention (patient A), a persisting cerebro-spinal ﬂuid
iso-intense substance defect remains. Coregistration of the pre-
and postoperative MRI indicates complete (patient A), and almost
complete (patient B), destruction of the deep cortical and directly
subcortical FLAIR-signal intensity attributed to the FCD IIB. As
intended, the transmantle sign was left unaffected in both cases. In
patient A, the superﬁcial cortical layers over the former FCD have
been maintained. The neighbouring sulcus, including its vessels,
remained intact.
In both patients, the preoperative seizure activity ceased.
Patient A (preoperatively 4–5 seizures per day) reported two
unprovoked seizures of atypical semiology compared to her
preoperative ones on post-operative days 56 and 57. Since these
events, she has been completely seizure free for 12 months despite
a self-initiated tapering of her preoperative medication from
450 mg to 125 phenytoin/day (last measured phenytoin blood
level: 1.7 mg/ml). Patient B (seizures almost every other night,
preoperatively) has had no seizures since surgery (5 months). He
has not yet signiﬁcantly tapered the medication.Following intervention, patient A had a transient mild paresis of
the left corner of her mouth (as expected from intraoperative
stimulation), but at no time did she have paresis of the hand.
Patient B had no neurological deﬁcit.
4. Discussion
These ﬁrst two cases of strongly lesion-focused RFTC are
signiﬁcant for two reasons. First, these cases provide evidence that
in a subset of epileptogenic lesions, the EZ may not exceed the MRI-
visible lesion and that lesion-oriented RFTC is a suitable surgical
tool to address this issue. Furthermore, they illustrate that RFTC is a
high precision surgical technique that can be applied close to
eloquent structures.
The overlap of epileptogenic lesions and the EZ is not self-
evident. Invasive EEG often shows interictal and ictal epileptic
discharge patterns that exceed the lesional area. These suggest that
epileptogenicity extends beyond the visible lesion margins.4
However, epileptic discharges beyond lesion limits could be due
to propagation effects outside that area that must be resected for
seizure freedom. Their signiﬁcance can only be determined by very
lesion-focused surgical strategies. We hope that our report will
stimulate further investigations to determine the effectiveness of
lesion destruction in eliminating seizure activity. This would be a
signiﬁcant further development of the concept of individually
tailored epilepsy surgery and could contribute to the discussion of
what the EZ/what-to-remove area is.
Small bottom-of-sulcus FCD IIB is a good candidate lesion entity
with which to begin research. Resections limited to the neocortical
lesion aspect achieve seizure freedom in >80% of the patients even
when the lesion extension towards the ventricle (transmantle
sign) remains in place.5 Detailed analysis of the coagulation defect
in patient A indicates that the RFTC left a small rim of superﬁcial,
non-lesional cortical layers intact over the lesion. Even this did not
preclude 12 months of seizure freedom despite a phenytoin blood
level that was close to zero at the last follow up visit. This
observation is suggestive of a restricted EZ within the FLAIR-signal
intense FCD. The signiﬁcance of the two atypical seizures on days
56 and 57 remains unclear. Possibly, these seizures are not
predictive of failure to achieve long-term seizure freedom, just as a
transient increase in simple-partial seizures following temporo-
mesial radio-therapy is believed to be non-prognostic. In patient B,
we cannot judge with certainty from the 2 month post-operative
MRI whether a part of the deep FLAIR-signal intensity has been
missed by RFTC (Fig. 1(B3), upper panel). This will become evident
from the 1 year post-operative MRI. Nevertheless, 5 months after
surgery, this patient is completely seizure free.
For lesion entities other than small bottom-of-sulcus FCD IIB,
RFTC should be performed only after careful consideration of its
limitations. RFTC does not supply tissue for histopathology.
Therefore, lesions with questionable dignity in the MRI should
preferably undergo resective surgery. For lesion entities for which
narrow lesionectomies usually do not lead to seizure freedom and
for lesions without clearly recognisable margins in MRI (including
more diffuse FCD), RFTC may also not be suited. The maximum
degree of morphological lesion complexity to which RFTC can be
applied and the maximum possible coagulation volume still needs
to be evaluated. We have applied up to 16 coagulation sites,
destroying approximately 1.5 cm3 of tissue. For larger lesions, a
multi-stage procedure is possible in theory, even a combination of
RFTC and open resection. The risk for procedure-associated
haemorrhage is low due to the implementation of a contrast-
enhanced 3D-T1 data set into the planning software. The danger of
damaging vessels by focal heating (i.e., in the depth of sulci) is
understood to be negligible because of the cooling effects of
circulation.
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in brain areas where conventional resection would carry a
signiﬁcant risk for persistent neurological deﬁcits. This observation
has been made before by other groups who applied stereotactic
RFTC to hypothalamic hamartomas10 and periventricular nodular
heterotopia.11
The volume-of-destruction achieved by RFTC can be anticipated
reliably. Commercially available brachytherapy software allows
the planning of complex three-dimensional ablations. The elective
situation of preoperative planning facilitates the integrating of
multimodal imaging information. During surgery, the validity of
presurgical assumptions regarding the epileptogenicity of the
lesion and the proximity or distance to eloquent structures can be
determined via the very electrode that is subsequently used for
coagulation. This feedback is an advantage of RFTC over other
destructive surgical techniques such as stereotactic radiosur-
gery.12 Another advantage over radiosurgery is that the lesions are
immediately destroyed without signiﬁcant oedema.
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thermo-coagulation of focal cortical dysplasia
II-B: A new approach to epilepsy surgery?
In this well-written paper the authors report stereotactic radio-
frequency thermo-coagulation in two patients with sulcal FCD.
Obviously this method was used after careful consideration, and
the outcome reported was satisfying.
It needs to be mentioned, however, that visible sulcal
thickening with a transmantle sign on MRI frequently is only
the tip of the iceberg of a dysplastic cortical region, under-
estimating the true extent of dyslamination. Approaching such
more extensive lesions with stereotactic interventions can
certainly not be advised.
Furthermore, even to achieve a well-localised area of destruc-
tion, thermocoagulation had to be performed at 16 or 14 sites,
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